| von Bergwelt-Baildon MS, Shimabukuro-Vornhagen A, Klein-Gonzalez N, et al.
T-Cell Responses to Cyclin B1 Are Not Restricted to p53-Overexpressing Tumors. [JOURNAL ARTICLE]
Clin Cancer Res 2009 Nov 10.
Abstract | Full Citation | Find Related Articles |
| Noguera R, Fredlund E, Piqueras M, et al.
HIF-1{alpha} and HIF-2{alpha} Are Differentially Regulated In vivo in Neuroblastoma: High HIF-1{alpha} Correlates Negatively to Advanced Clinical Stage and Tumor Vascularization. [JOURNAL ARTICLE]
Clin Cancer Res 2009 Nov 10.
Abstract | Full Citation | Find Related Articles |
| Damiano V, Garofalo S, Rosa R, et al.
A Novel Toll-Like Receptor 9 Agonist Cooperates with Trastuzumab in Trastuzumab-Resistant Breast Tumors through Multiple Mechanisms of Action. [JOURNAL ARTICLE]
Clin Cancer Res 2009 Nov 10.
Abstract | Full Citation | Find Related Articles |
| Myers AP, Meyerhardt JA, Cantley LC
Getting Knit-PI3Ky: PIK3CA Mutation Status to Direct Multimodality Therapy? [JOURNAL ARTICLE]
Clin Cancer Res 2009 Nov 10.
Abstract | Full Citation | Find Related Articles |
| Mai W, Kawakami K, Shakoori A, et al.
Deregulated GSK3{beta} Sustains Gastrointestinal Cancer Cells Survival by Modulating Human Telomerase Reverse Transcriptase and Telomerase. [JOURNAL ARTICLE]
Clin Cancer Res 2009 Nov 10.
Abstract | Full Citation |
| Sredni ST, Gadd S, Huang CC, et al.
Subsets of Very Low Risk Wilms Tumor Show Distinctive Gene Expression, Histologic, and Clinical Features. [JOURNAL ARTICLE]
Clin Cancer Res 2009 Nov 10.
Abstract | Full Citation | Find Related Articles |
| Bello CL, Mulay M, Huang X, et al.
Electrocardiographic Characterization of the QTc Interval in Patients with Advanced Solid Tumors: Pharmacokinetic- Pharmacodynamic Evaluation of Sunitinib. [JOURNAL ARTICLE]
Clin Cancer Res 2009 Nov 10.
Abstract | Full Citation |
| He Y, Van't Veer LJ, Mikolajewska-Hanclich I, et al.
PIK3CA Mutations Predict Local Recurrences in Rectal Cancer Patients. [JOURNAL ARTICLE]
Clin Cancer Res 2009 Nov 10.
Abstract | Full Citation | Find Related Articles |
| O'Connor OA, Stewart AK, Vallone M, et al.
A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of the Novel Proteasome Inhibitor Carfilzomib (PR-171) in Patients with Hematologic Malignancies. [JOURNAL ARTICLE]
Clin Cancer Res 2009 Nov 10.
Abstract | Full Citation |
| Lacelle MG, Jensen SM, Fox BA
Partial CD4 Depletion Reduces Regulatory T Cells Induced by Multiple Vaccinations and Restores Therapeutic Efficacy. [JOURNAL ARTICLE]
Clin Cancer Res 2009 Nov 10.
Abstract | Full Citation | Find Related Articles |
  |
